Kwality Pharmaceuticals Limited (BOM:539997)
India · Delayed Price · Currency is INR 3,671.45
+41.80 (1.15%)
At close: Sep 25, 2026
Kwality Pharmaceuticals Market Cap
Kwality Pharmaceuticals has a market cap or net worth of 38.1 billion as of September 25, 2026. Its market cap has increased by 282.90% in one year.
Market Cap
38.10B
Enterprise Value
39.35B
Revenue
5.54B
Ranking
n/a
PE Ratio
47.01
Stock Price
3,671.45
ChartMarket Cap Chart
Since July 18, 2016, Kwality Pharmaceuticals's market cap has increased from 230.87M to 38.10B, an increase of 16,400.90%. That is a compound annual growth rate of 65.01%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 25, 2026 | 38.10B | 231.25% |
| Dec 31, 2025 | 11.50B | 27.87% |
| Dec 31, 2024 | 8.99B | 116.81% |
| Dec 29, 2023 | 4.15B | 5.27% |
| Dec 30, 2022 | 3.94B | -58.55% |
| Dec 31, 2021 | 9.51B | 1,561.38% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 21, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Bliss GVS Pharma | 75.38B |
| Sanofi India | 72.31B |
| Morepen Laboratories | 66.00B |
| FDC Limited | 55.53B |
| Novartis India | 48.43B |
| Gufic Biosciences | 42.41B |
| Unichem Laboratories | 38.74B |
| Hikal | 26.87B |